Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults

NCT02757755 is registered in ClinicalTrials.gov with Armata Pharmaceuticals, Inc. as lead sponsor.

NCT NCT02757755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02757755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults
Lead sponsor
Armata Pharmaceuticals, Inc.
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2016
Completion date
August 31, 2016
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers